{
    "2021-10-27": [
        [
            {
                "time": "2021-08-29",
                "original_text": "华东医药：公司全球独家胶原蛋白刺激剂长效微球Ellansé®伊妍仕®已于8月29日正式登陆中国大陆市场",
                "features": {
                    "keywords": [
                        "华东医药",
                        "Ellansé",
                        "伊妍仕",
                        "医美",
                        "胶原蛋白刺激剂"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-Q3",
                "original_text": "华西证券维持华东医药增持评级：Q3业绩环比实现增长，医药创新和医美业务布局稳步推进",
                "features": {
                    "keywords": [
                        "华西证券",
                        "华东医药",
                        "Q3业绩",
                        "医美业务",
                        "医药创新"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-H1",
                "original_text": "华东医药：采用OXIFREE专利技术和工艺的新型高端含利多卡因玻尿酸填充MaiLi®系列产品已于2021年上半年在欧洲市场上市",
                "features": {
                    "keywords": [
                        "华东医药",
                        "MaiLi",
                        "玻尿酸",
                        "欧洲市场",
                        "上市"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-Q1-Q3",
                "original_text": "安信证券给予华东医药买入评级，2021Q1-Q3医美业务快速增长，医美管线潜力有望逐步释放",
                "features": {
                    "keywords": [
                        "安信证券",
                        "华东医药",
                        "医美业务",
                        "快速增长",
                        "管线潜力"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-全年",
                "original_text": "华东医药今年前三季增收不增利，医美业务有望超额完成全年目标",
                "features": {
                    "keywords": [
                        "华东医药",
                        "前三季",
                        "增收不增利",
                        "医美业务",
                        "超额完成"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2025-目标",
                "original_text": "华东医药：力争实现2025年创新业务板块占整体工业营收30%的阶段性目标",
                "features": {
                    "keywords": [
                        "华东医药",
                        "创新业务",
                        "2025目标",
                        "工业营收"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "创新"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}